Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Menstrual Disorders Related to Eating Disorders.
Milano W, Ambrosio P, Carizzone F, De Biasio V, Foia MG, Saetta B, Milano MF, Capasso A. Milano W, et al. Among authors: capasso a. Endocr Metab Immune Disord Drug Targets. 2022;22(5):471-480. doi: 10.2174/1871530321666210625145345. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 34182917
Neuroendocrine and Metabolic Disorders in Bulimia Nervosa.
Milano W, Capasso A. Milano W, et al. Among authors: capasso a. Endocr Metab Immune Disord Drug Targets. 2018;18(4):297-305. doi: 10.2174/1871530318666171212092725. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29231147 Review.
Medical Complications in Anorexia and Bulimia Nervosa.
Gravina G, Milano W, Nebbiai G, Piccione C, Capasso A. Gravina G, et al. Among authors: capasso a. Endocr Metab Immune Disord Drug Targets. 2018;18(5):477-488. doi: 10.2174/1871530318666180531094508. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29848283 Review.
Gender Dysphoria, Eating Disorders and Body Image: An Overview.
Milano W, Ambrosio P, Carizzone F, De Biasio V, Foggia G, Capasso A. Milano W, et al. Among authors: capasso a. Endocr Metab Immune Disord Drug Targets. 2020;20(4):518-524. doi: 10.2174/1871530319666191015193120. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31644411 Review.
Eating Disorders in Athletes: From Risk Management to Therapy.
Milano W, Milano L, Capasso A. Milano W, et al. Among authors: capasso a. Endocr Metab Immune Disord Drug Targets. 2020;20(1):2-14. doi: 10.2174/1871530319666190418121446. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31684854 Review.
Neurobiological Correlates Shared Between Obesity, BED and Food Addiction.
Milano W, Carizzone F, De Biasio V, Angela Mercorio M, Francesca Milano M, Saetta B, Capasso A. Milano W, et al. Among authors: capasso a. Endocr Metab Immune Disord Drug Targets. 2023;23(3):283-293. doi: 10.2174/1871530322666220627125642. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35761485 Review.
Recent clinical aspects of eating disorders.
Capasso A, Putrella C, Milano W. Capasso A, et al. Rev Recent Clin Trials. 2009 Jan;4(1):63-9. doi: 10.2174/157488709787047594. Rev Recent Clin Trials. 2009. PMID: 19149764 Review.
Night eating syndrome: an overview.
Milano W, De Rosa M, Milano L, Capasso A. Milano W, et al. Among authors: capasso a. J Pharm Pharmacol. 2012 Jan;64(1):2-10. doi: 10.1111/j.2042-7158.2011.01353.x. Epub 2011 Sep 27. J Pharm Pharmacol. 2012. PMID: 22150667 Review.
391 results